163 related articles for article (PubMed ID: 22814953)
21. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
22. Cancer cell stemness, responses to experimental genotoxic treatments, cytomegalovirus protein expression and DNA replication stress in pediatric medulloblastomas.
Bartek J; Merchut-Maya JM; Maya-Mendoza A; Fornara O; Rahbar A; Bröchner CB; Sehested A; Söderberg-Nauclér C; Bartek J; Bartkova J
Cell Cycle; 2020 Apr; 19(7):727-741. PubMed ID: 32054408
[TBL] [Abstract][Full Text] [Related]
23. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
[TBL] [Abstract][Full Text] [Related]
24. The pathological characteristics of glioma stem cell niches.
He H; Li MW; Niu CS
J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
[TBL] [Abstract][Full Text] [Related]
25. Stem cell markers in gliomas.
Dell'Albani P
Neurochem Res; 2008 Dec; 33(12):2407-15. PubMed ID: 18493853
[TBL] [Abstract][Full Text] [Related]
26. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
Li MW; Niu CS
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
[TBL] [Abstract][Full Text] [Related]
27. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
[TBL] [Abstract][Full Text] [Related]
28. [Polysialylated NCAM in CSF, a marker for invasive medulloblastoma].
Dubois C; Figarella-Branger D; Rougon G; Rampini C
C R Seances Soc Biol Fil; 1998; 192(2):289-96. PubMed ID: 9759372
[TBL] [Abstract][Full Text] [Related]
29. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
30. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
31. Embryonic Stem Cell-Related Protein L1TD1 Is Required for Cell Viability, Neurosphere Formation, and Chemoresistance in Medulloblastoma.
Santos MC; Silva PB; Rodini CO; Furukawa G; Marco Antonio DS; Zanotto-Filho A; Moreira JC; Okamoto OK
Stem Cells Dev; 2015 Nov; 24(22):2700-8. PubMed ID: 26159230
[TBL] [Abstract][Full Text] [Related]
32. A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.
Sherman JH; Redpath GT; Redick JA; Purow BW; Laws ER; Jane JA; Shaffrey ME; Hussaini IM
J Neurosci Methods; 2011 May; 198(1):99-102. PubMed ID: 21402102
[TBL] [Abstract][Full Text] [Related]
33. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.
Sutter R; Shakhova O; Bhagat H; Behesti H; Sutter C; Penkar S; Santuccione A; Bernays R; Heppner FL; Schüller U; Grotzer M; Moch H; Schraml P; Marino S
Oncogene; 2010 Mar; 29(12):1845-56. PubMed ID: 20062081
[TBL] [Abstract][Full Text] [Related]
34. B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells.
Yao Y; Wang X; Jin K; Zhu J; Wang Y; Xiong S; Mao Y; Zhou L
J Neurooncol; 2008 Sep; 89(2):121-9. PubMed ID: 18478183
[TBL] [Abstract][Full Text] [Related]
35. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
38. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease.
Sharma BK; Manglik V; Elias EG
J Surg Res; 2010 Sep; 163(1):e11-5. PubMed ID: 20638684
[TBL] [Abstract][Full Text] [Related]
39. An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.
Wang B; Yu SC; Jiang JY; Porter GW; Zhao LT; Wang Z; Tan H; Cui YH; Qian C; Ping YF; Bian XW
Stem Cell Rev Rep; 2011 Jun; 7(2):458-70. PubMed ID: 20809257
[TBL] [Abstract][Full Text] [Related]
40. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro.
Nikolova T; Wu M; Brumbarov K; Alt R; Opitz H; Boheler KR; Cross M; Wobus AM
Differentiation; 2007 Feb; 75(2):100-11. PubMed ID: 17316380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]